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Abstract
Background: We aimed to evaluate associations of right atrial (RA) and right ventricular (RV) strain parameters
assessed by 2D speckle tracking echocardiography (2D STE) with invasively measured hemodynamic parameters in
patients with and without pulmonary hypertension (PH).
Methods: In this study, we analyzed 78 all-comer patients undergoing invasive hemodynamic assessment by left
and right heart catheterization. Standard transthoracic echocardiographic assessment was performed under the
same hemodynamic conditions. RA and RV longitudinal strain parameters were analyzed using 2D STE. PH was
defined as invasively obtained mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest and was further divided
into pre-capillary PH (pulmonary capillary wedge pressure [PCWP] ≤ 15 mmHg), post-capillary PH (PCWP > 15
mmHg) and combined PH (PCWP > 15 mmHg and difference between diastolic PAP and PCWP of ≥7 mmHg).
Correlation analyses between variables were calculated with Pearson’s or Spearman’s correlation coefficient as
applicable.
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: lena.theres@charite.de
†Anna Brand and Bernd Hewing share senior authorship
1Medizinische Klinik m.S. Kardiologie und Angiologie,
Charité-Universitätsmedizin, Campus Mitte, Charitéplatz 1, 10117 Berlin,
Germany
2DZHK (German Center for Cardiovascular Research), partner site, Berlin,
Germany
Full list of author information is available at the end of the article
Theres et al. Cardiovascular Ultrasound           (2020) 18:13 
https://doi.org/10.1186/s12947-020-00197-z
(Continued from previous page)
Results: Out of 78 patients, 45 presented with PH. Within the PH group, 39 had post-capillary, five had combined
pre- and post-capillary PH, and one had pre-capillary PH. Patients with PH had a significantly increased RA area (PH
22.0 ± 9.2 cm2, non-PH 17.3 ± 10.7 cm2; p = 0.003) and end-systolic RV area (PH 14.7 ± 6.1, non-PH 11.9 ± 4.8 cm2;
p = 0.022). RV mid strain was significantly reduced in PH (PH -17.4 ± 7.8, non-PH: − 21.6 ± 5.5; p = 0.019). Average
peak systolic RA strain (RAS) and average peak systolic RV strain (RVS) showed a significant association with mPAP
(r = − 0.470, p = 0.001 and r = 0.490, p = 0.001, respectively) and with PCWP (r = − 0.296, p = 0.048 and r = 0.365, p =
0.015, respectively) in patients with PH. Furthermore, RV apical, mid and basal strain as well as RV free wall strain
showed moderate associations with mPAP. In patients without PH, there were no associations detectable between
RA or RV strain parameters and mPAP and PCWP.
Conclusion: In an all-comer cohort, RA and RV strain parameters showed significant associations with invasively
assessed mPAP and PCWP in patients with predominantly post-capillary PH. These associations may be useful in
clinical practice to assess the impact of post-capillary PH on myocardial right heart function.
Keywords: Right atrial strain, Right ventricular strain, Pulmonary hypertension, 2D speckle tracking
echocardiography, Post-capillary pulmonary hypertension, Hemodynamic
Introduction
While diagnosis of PH is based on invasive hemodynamic
measurements of pulmonary artery pressure (PAP) by
right heart catheterization, transthoracic echocardiog-
raphy (TTE) remains the widely available screening and
monitoring tool for PH. According to current PH guide-
lines [1], estimation of systolic PAP is recommended in
patients with tricuspid regurgitation by Doppler Imaging.
Recommendations, however, on functional assessment of
RA and RV impairment due to PH remain scarce. Recent
studies have shown that RA and RV dysfunction are im-
portant prognostic factors and indicators for adverse out-
come in patients with pre-capillary PH [2–5]. 2D STE
reportedly constitutes a feasible additional tool for the as-
sessment of RA and RV function [6, 7] and normative ref-
erence data for RA and RV 2D STE have been published
for healthy populations [8–10]. Furthermore, the prognos-
tic value of RA and RV strain parameters has been evalu-
ated in patients with pre-capillary PH [11, 12]. However,
studies assessing the association of RA and RV mechanics
with invasively obtained parameters in patients with PH
remain sparse and exist primarily for pre-capillary PH [4,
13, 14]. Thus, this study aimed to evaluate associations of
RA and RV strain values assessed by 2D STE with inva-
sively measured hemodynamic parameters in patients PH
from an all-comer cohort of a cardiology department.
Methods
Study design and population
This study is a retrospective analysis of a single-center
database of the Cardiology Department, Charité-Univer-
sitätsmedizin Berlin, Campus Mitte, Germany. 78 pa-
tients were enrolled in the study in the years 2013 to
2015. All underwent hemodynamic assessment by left
and right heart catheterization and had a comprehensive
TTE examination within 24 h periprocedural (median
3.2 h). A comprehensive medical history was collected in
all study participants by clinical interview at admission
and by medical records. Exclusion criteria were ongoing
mechanical ventilation, presence of severe mitral valve
stenosis, mechanical prosthetic heart valves, heart trans-
plantation, and insufficient image quality. PH was de-
fined as an invasively measured mPAP of ≥25mmHg at
rest [1]. We distinguished between pre-capillary PH,
which is defined as an elevated mPAP of ≥25mmHg but
normal PCWP ≤15mmHg, and post-capillary PH, where
mPAP and PCWP are both elevated (mPAP ≥25 mmHg
and PCWP > 15mmHg) [1]. Combined pre- and post-
capillary PH was defined as an elevated PCWP and dia-
stolic pressure gradient (defined as the difference be-
tween diastolic PAP and PCWP) of ≥7 mmHg [1].
The study has been approved by the institutional eth-
ics committee of the Charité-Universitätsmedizin Berlin
(EA4/067/13) and complied with the Declaration of
Helsinki.
Echocardiographic examination
A comprehensive TTE was performed using a Vivid 7
Dimension or Vivid E9 (GE Vingmed, Horton, Norway;
M4S or M5S 1.5–4.5MHz transducer) ultrasound sys-
tems. All investigators in the echocardiography labora-
tory were blinded for invasively obtained data. Standard
left and right heart echocardiographic parameters were
obtained according to the recommendations of the
American Society of Echocardiography (ASE) and Euro-
pean Association of Cardiovascular Imaging (EACVI)
[15, 16]. These included measurement of tricuspid annu-
lar plane systolic excursion (TAPSE) with M-Mode and
RV peak systolic velocity (RV-S′) with Doppler tissue
imaging (DTI). Three beats of each view were recorded
for offline analysis (EchoPac PC, GE Vingmed). RA area
and RV diameter (basal, mid and apico-basal) were
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measured directly from 2D images according to the rec-
ommendations of ASE and EACVI [15, 16]. Endocardial
borders of the RV were traced in an apical four-chamber
view for detection of end-diastolic and end-systolic RV
area (RVED and RVES area, respectively) and RV frac-
tional area change (FAC) was calculated. Left ventricular
ejection fraction (LVEF) was calculated using biplane
Simpson’s method and Auto-EF tool (GE Vingmed) as
previously described [17].
2D speckle tracking strain analysis
For longitudinal strain analyses, multiple standard 2D
ultrasound images were recorded with a frame rate be-
tween 60 and 80 frames per second and digitally stored
for offline analysis (EchoPac PC, GE Vingmed). After
manual tracing of the endocardial border of the RA, RV
and left ventricle (LV) [18, 19], the region of interest
(ROI) was semi-automatically determined. The ROI was
manually adjusted for optimal tracking quality when ne-
cessary. For all strain analyses, an arithmetic mean value
of three individual measurements was used.
For phasic RA strain assessment, a RV-focused four
chamber view, avoiding foreshortening of the RA, was
chosen. Phasic RA strain analyses were performed using
2D speckle tracking echocardiography [19] identifying
strain values during the three phases of the RA cycle
from the resulting strain curves (see Fig. 1 for illustra-
tion). The maximum excursion of the average strain
curve (dotted line in Fig. 1) symbolizes the maximum
longitudinal strain and RA reservoir function (RAS).
Next, RA conduit function was calculated from the dif-
ference of strain values of conduit phase in early diastole
(onset of the atrial contraction) and RAS, while RA con-
traction function was derived from the difference be-
tween the endpoint of conduit phase (at the onset of
atrial contraction) and the peak negative RA strain
shortening (RA contraction, see Fig. 1) [19]. In patients
with atrial fibrillation, RA conduit and contractile func-
tion was not obtained.
For longitudinal RV strain analyses, a RV-focused ap-
ical four-chamber view was used. We analyzed RV strain
in four segments, three of them being part of the RV free
wall (basal, mid and apical segment) as well as the inter-
ventricular septum (see Fig. 2 for illustration). Combin-
ing the average peak systolic strain of all RV segments
resulted in an average RV strain (RVS), while RV free
wall comprises the average strain of all three free wall
segments.
LV global longitudinal peak systolic strain (LV-GLPS)
was measured semi-automatically by strain analyses of
the apical four-, three- and two-chamber-view as previ-
ously described [17].
Cardiac catheterization
All patients had a clinical indication for a combined right
and left heart catheterization. Cardiac catheterization
measurements were performed as previously described
[17]. Briefly, arterial and venous accesses were established
by inserting sheaths in the femoral artery and vein, re-
spectively. Then a fluid-filled pigtail catheter (6 French,
Cordis, a Cardinal Health company) was placed in the LV
for LV end-diastolic pressure (LVEDP) measurements.
For measurements of right heart pressures, pulmonary ar-
tery pressure (PAP) and PCWP a Corodyn P1 right heart
Fig. 1 Representative example of speckle tracking echocardiography (2D STE-) derived longitudinal strain of the right atrium obtained in the
apical 4-chamber view. Dotted white curve indicates mean of all segments. The maximum excursion of the average strain curve [1] symbolizes
the maximum longitudinal strain and RA reservoir function (RAS). RA conduit function was calculated from the difference between RAS and the
end of the conduit phase in early diastole [2] and RA contractile function was derived from the difference between the endpoint of conduit
phase and the peak RA contraction [3]
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catheter (B. Braun, Germany) was used. Exact wedge pos-
ition was verified by changes in pressure waveforms and
fluoroscopy. Cardiac index, systemic vascular resistance
(SVR) and pulmonary vascular resistance (PVR) were cal-
culated as previously described [17]. All patients were
hemodynamically stable at the time of the examination.
All measurements were acquired during an unforced end
expiratory breath-hold and were completed before injec-
tion of contrast agents into the left ventricle or coronary
arteries was performed.
Intra- und inter-observer agreement
To determine intra- and interobserver variability for RA
and RV strain parameters, a second experienced cardi-
ologist, who was blinded to previously obtained data,
separately measured RA and RV strain parameters of 20
randomly selected patients. Intraclass correlation coeffi-
cients (ICC) were calculated for RVS, RAS, RA conduit
and contractile function.
Statistical analysis
Statistical analysis was performed using SPSS (Version
25, IBM Corporation). For continuous variables, results
are expressed as arithmetic mean and standard deviation
(SD) or, if not normally distributed variables, as median
with interquartile ranges (IQR = 25th–75th percentile).
Accordingly, Student’s t-test or Mann-Whitney U test
was used for comparison of groups. Categorical data are
presented as absolute numbers and respective percent-
ages. Categorical variables were compared by chi-square
tests. For correlation analyses between variables, Pear-
son’s or Spearman’s correlation coefficient were




A total of 78 patients were enrolled in the present study.
45 patients presented with PH, while 33 patients had no
signs of PH (non-PH). Within the PH group, 39 had
post-capillary, five had combined pre- and post-capillary
PH, and one had pre-capillary PH. Baseline clinical and
demographic characteristics of all patients and individual
groups of PH and non-PH patients are listed in Table 1.
None of the patients had tricuspid or pulmonary valve
stenosis.
Echocardiographic and invasive characteristics
Detailed cardiac catheterization and echocardiographic
data of all patients and individual groups of PH and
non-PH patients are presented in Table 2. Invasively
assessed mPAP, PWCP, and LVEDP were significantly
higher in PH compared to non-PH patients while car-
diac index was significantly lower in the PH group
(Table 2). Patients with PH had significantly larger RA
and RV end-systolic area (RVES area) compared to non-
PH patients. TAPSE, RV-S′, LVEF, and LV-GPLS were
significantly lower in the PH group (Table 2).
Due to the presence of atrial fibrillation at examin-
ation, assessment of RA conduit and contractile function
was limited to 59 patients (PH n = 30, non-PH n = 29).
RA and RV strain was reduced in the PH group but the
difference did not reach statistical significance except for
average mid RV strain (Table 3).
Fig. 2 Representative example of speckle tracking echocardiography (2D STE-) derived longitudinal strain of the right ventricle obtained in the
apical 4-chamber view. Dotted white curve indicates mean of all segments, where RVS is derived from maximum excursion. The RV Free wall
consists of three segments, which are colored red, dark blue and pink in the STE analysis
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Associations between echocardiographic standard and
deformation parameters and invasive characteristics
Associations between echocardiographic and invasively
assessed parameters are listed in Table 4. There were no
significant associations between echocardiographically
assessed right heart parameters and invasively measured
mPAP and PCWP in non-PH patients. In PH patients,
RAS showed a significant inverse association with mPAP
(r = − 0.470, p = 0.001) and with PCWP (r = − 0.296, p =
0.048), while RA conduit and contractile function did not
show any significant associations with mPAP or PCWP.
Concerning RV parameters, moderate associations be-
tween mPAP and RVS (r = 0.490, p = 0.001), RV free wall
strain (r = 0.466, p = 0.002), RV mid strain(r = 0.444, p =
0.003) or RV apical strain (r = 0.461, p = 0.002) were found
in PH patients. Associations between mPAP and TAPSE
(r = 0.378, p = 0.010), RV-S′ (r = 0.323, p = 0.037), RVED
area (r = 0.382, p = 0.012), or RV base diameter (r = 0.346,
p = 0.023) were weak to moderate.
There were significant associations between PCWP and
RVED area (r = 0.389, p = 0.019), RVES area (r = 0.338,
p = 0.027), RVS (r = 0.365, p = 0.015), RV base diameter
(r = 0.318, p = 0.038), or RV apical strain (r = 0.348, p =
0.220). While there was a significant difference in RA area
between patients with PH and without PH, there was no
significant association of RA area with mPAP or PCWP.
RVOT VTI and RV-a’ showed weak to moderate asso-
ciations with RAS and RVS (RVOT VTI: r = 0.244, p =
0.042; r = − 0.306, p = 0.015 for RAS and RVS; RV-a’: r =
0.405, p = 0.001; and r = − 0,256, p = 0,055 for RAS and
RVS; respectively). Some of the clinical characteristics
with possible impact on PH diagnosis were different be-
tween groups; however, none of these parameters
showed significant associations with the diagnosis of PH
in a multivariate logistic regression model (see Supple-
ment, Tables S1 and S2).
Intra- and inter-observer agreement
The ICC for intra-observer agreement was 0.86 (95%
confidence interval [CI] 0.68–0.94) for RAS, 0.88 (CI
0.73–0.95) for RA conduit function, 0.86 (CI 0.68–0.94)
for RA contractile function and 0.75 (CI 0.48–0.89) for
RVS. ICC for inter-observer agreement was 0.92 (CI
0.81–0.97), 0.89 (CI 0.75–0.95), 0.82 (CI 0.61–0.92) and
0.91 (CI 0.8–0.96), respectively.
Discussion
In the present study, we analyzed echocardiographically
and invasively assessed hemodynamic parameters in a
cohort of all-comer patients with and without PH. We
demonstrated significant associations between right
heart deformation parameters (2D STE-derived RA and
Table 1 Baseline characteristics
Characteristic All (n = 78) PH (n = 45) Non-PH (n = 33) p-value
Number of patients, n (%) 78 45 (57.7) 33 (42.3)
Age, years 72.6 ± 12.8 75.1 ± 11.5 69.3 ± 13.9 0.049
Gender female/male, n (%) 17 (22.0) / 61 (78.0) 16 (35.6) / 29 (64.4) 32 (97.0)/ 1 (3.0) 0.001
BMI, kg/m2 26.0 (24.0–29.4) 26.7 (24.0–29.5) 24.9 (24.0–27.8) 0.107
Heart rate, /min 71.0 ± 12.3 72.6 ± 13.4 68.8 ± 10.2 0.181
SBP, mmHg 137.0 (118.7–150.0) 137.0 (116.0–149.0) 137.0 (121.5–153.5) 0.671
DBP, mmHg 68.4 ± 12.3 68.9 ± 13.3 67.8 ± 11.1 0.693
AF, n (%) 21 (26.9) 16 (35.6) 5 (15.2) 0.045
Diabetes, n (%) 23 (29.5) 17 (37.8) 6 (18.2) 0.061
Arterial hypertension, n (%) 56 (71.8) 35 (77.8) 21 (63.6) 0.170
CAD, n (%) 33 (42.3) 24 (53.3) 9 (27.3) 0.021
Previous MI, n (%) 13 (16.7) 10 (22.2) 3 (9.1) 0.124
Previous CABG, n (%) 7 (9.0) 6 (13.3) 1 (3.0) 0.116
Previous TIA/stroke, n (%) 5 (6.4) 3 (6.7) 2 (6.1) 0.914
PAD, n (%) 8 (10.3) 6 (13.3) 2 (6.1) 0.296
Previous bAVR, n (%) 4 (5.1) 3 (6.7) 1 (3.0) 0.472
PM, n (%) 14 (17.9) 10 (22.2) 4 (12.1) 0.251
ICD, n (%) 2 (2.6) 2 (4.4) 0 0.220
COPD, n (%) 16 (20.5) 13 (28.9) 3 (9.1) 0.032
Data are expressed as mean ± SD, median with IQR or absolute numbers and respective percentages. AF, atrial fibrillation; BMI, body mass index; SBP, systolic
blood pressure; DBP, diastolic blood pressure; CAD, coronary artery disease; MI, myocardial infarction; CABG, coronary artery bypass grafting; TIA, transient
ischemic attack; PAD, peripheral artery disease; bAVR, bioprosthetic aortic valve replacement; PM, pace maker; ICD, implantable cardioverter defibrillator; COPD,
chronic obstructive pulmonary disease.
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Table 2 Echocardiographic and cardiac catheterization data
Parameter All (n = 78) PH (n = 45) Non-PH (n = 33) p-value
Echocardiographic data
RA area, cm2 16.9 (13.0–24.9) 20.2 (15.8–27.0) 14.2 (12.3–18.0) 0.003
RVED area, cm2 21.9 (17.9–25.6) 22.1 (18.7–27.3) 20.4 (15.8–25.4) 0.130
RVES area, cm2 12.2 (9.9–15.6) 13.1 (10.8–17.1) 10.7 (9.3–13.4) 0.022
FAC, % 41.3 (32.7–49.1) 41.0 (33.0–48.4) 43.5 (32.3–53.3) 0.749
RV base diameter, mm 38.2 (33.5–42.9) 39.6 (34.6–43.9) 36 (30.3–40.7) 0.104
RV mid diameter, mm 26.6 (22.1–32.7) 29.3 (22.4–34.6) 24.8 (21.5–31.5) 0.146
RV apex-base diameter, mm 77.4 (66.3–84.2) 77.6 (66.3–84.9) 75.8 (66.4–81.8) 0.402
RVOT mm 32.3 ± 4.3 32.5 ± 4.1 31.8 ± 4.5 0.54
TAPSE, mm 19.8 ± 5.6 17.8 ± 5.4 22.3 ± 4.7 < 0.001
RV-S′, cm/s 10.9 ± 3.1 10.0 ± 3.1 12.2 ± 2.6 0.003
RVOT VTI 13.1. ± 4.0 12.0 ± 4.2 14.6 ± 3.2 0.006
RV-e‘cm/s 10.7 ± 3.3 10.6 ± 3.8 10.7 ± 2.7 0.76
RV-a’cm/s 12.7 ± 5.6 11.3 ± 6.4 14.2 ± 4.3 0.045
LV ejection fraction, % 45.0 ± 13.4 39.0 ± 12.4 52.4 ± 11.0 < 0.001
≥ 55, n (%) 25 (32.1) 8 (17.8) 17 (51.5)
45–54, n (%) 17 (21.8) 8 (17.8) 9 (27.3)
30–44, n (%) 27 (34.6) 21 (46.7) 6 (18.2)
≤ 30, n (%) 9 (11.5) 8 (17.8) 1 (3.0)
LV-GPLS −13.6 ± 5.5 −11.2 ± 5.3 −16.5 ± 4.3 < 0.001
Aortic valve regurgitation, n (%) 0.122
none 42 (53.8) 20 (44.4) 22 (66.7)
mild 25 (32.1) 16 (35.6) 9 (27.3)
moderate 9 (11.5) 8 (17.8) 1 (3)
severe 2 (2.6) 1 (2.2) 1 (3)
Aortic valve stenosis, n (%) 0.544
none 54 (69.2) 29 (64.4) 25 (75.8)
mild 1 (1.3) 1 (2.2) 0
moderate 1 (1.3) 1 (2.2) 0
severe 22 (28.2) 14 (31.1) 8 (24.2)
Mitral valve regurgitation, n (%) 0.002
none 16 (20.5) 8 (17.8) 8 (24.2)
mild 27 (34.6) 9 (20.0) 18 (54.5)
moderate 30 (38.5) 25 (55.6) 5 (15.2)
severe 5 (6.4) 3 (6.7) 2 (6.1)
Mitral valve stenosis, n (%) 0.675
none 75 (96.2) 43 (95.6) 32 (97.0)
mild 2 (2.6) 1 (2.2) 1 (3.0)
moderate 1 (1.3) 1 (2.2) 0
Tricuspid valve regurgitation, n (%) < 0.001
none 18 (23.1) 5 (11.1) 13 (39.4)
mild 31 (39.7) 16 (35.6) 15 (45.5)
moderate 21 (26.9) 16 (35.6) 5 (15.2)
severe 8 (10.3) 8 (17.8) 0
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RV strain) and invasively assessed mPAP and PCWP in
patients with predominantly post-capillary PH, while no
significant associations were found in non-PH patients.
To our knowledge, this is the first study providing a
comprehensive analysis of right heart strain parameters
in comparison with invasive hemodynamic measure-
ments in patients with predominantly post-capillary PH.
Imaging of the right heart, especially of the RA, by
TTE often remains challenging. Since we mainly exam-
ined patients with post-capillary PH which also have sev-
eral left heart and valve diseases, imaging of the right
heart can become even more challenging. Still 2D TTE
remains the most widely accessible and used diagnostic
tool in cardiology and additional methods like STE are
needed to extend the information derived from TTE in
different clinical settings. Several studies such as Pade-
letti et al. [9] and Peluso et al. [10] have shown that STE
is a valuable and practicable method for RA and RV
function assessment.
PH causes an increase of RV afterload with consecu-
tive elevation of RV pressures, which require adaptation
methods of the RV such as intensifying contraction and
increasing muscle mass (myocardial hypertrophy). This
can result in impairment of RV systolic function, making
parameters for RV systolic function such as RVS some
of the most valuable predictors for outcome in patients
with PH [20]. Previous studies [13, 14, 21] reported im-
paired RA and RV strain values in patients with pre-
capillary PH. Similarly, in our study RA strain values
were lower and RV strain values higher in PH patient
compared to non-PH patient. While PH patients in our
study consisted of an all-comer cohort and mainly repre-
sented patients with post-capillary PH caused by left
heart diseases, previous studies that reported significant
Table 2 Echocardiographic and cardiac catheterization data (Continued)
Parameter All (n = 78) PH (n = 45) Non-PH (n = 33) p-value
Pulmonary valve regurgitation, n (%) 0.060
none 50 (64.1) 24 (53.3) 26 (78.8)
mild 27 (34.6) 20 (44.4) 7 (21.2)
severe 1 (1.3) 1 (2.2) 0
Catheterization data
mPAP, mmHg 28.0 (21.0–36.0) 35.0 (30.0–42.5) 20.0 (17.0–22.5) < 0.001
PCWP, mmHg 20.0 ± 9.0 25.9 ± 6.8 11.8 ± 3.9 < 0.001
Cardiac index, ml/min/m2 2.2 ± 0.6 2.0 ± 0.6 2.4 ± 0.4 0.001
LVEDP, mmHg 20.0 (14.5–27.5) 24.5 (21.0–30.7) 15.0 (13.0–17.5) < 0.001
SVR, dyn x sec x cm−5 1619.5 (1345–2029.0) 1712.0 (1344–2178.0) 1536.0 (1334–1794.0) 0.189
PVR, dyn x sec x cm−5 205.5 (138.2–251.0) 212.0 (164.5–288.5) 180.0 (111.0–238.5) 0.056
Data are expressed as mean ± SD, median with IQR, or absolute numbers and respective percentages. PH, pulmonary hypertension; RA, right atrial; RV, right
ventricular; RVED and RVES, RV end diastolic and end systolic; FAC, fractional area change; TAPSE, tricuspid annular plane systolic excursion; RV-S′, RV peak systolic
velocity; LV-GLPS, left ventricular global longitudinal peak systolic strain; LVEDP, left ventricular enddiastolic pressure; mPAP, mean pulmonary artery pressure;
PCWP, pulmonary capillary wedge pressure; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance
Table 3 Right atrial (RA) and right ventricular (RV) strain parameters
Parameter All (n = 78) PH (n = 45) Non-PH (n = 33) p-value
RA strain parameters
RAS, % 19.5 (10.4–26.9) 14.8 (7.5–26.3) 21.3 (15.3–29.9) 0.060
Conduit function, %* 10.0 (5.8–14.7) 7.5 (3.7–14.7) 11.7 (7.6–15.6) 0.063
Contractile function, %* 11.8 (8.4–15.8) 11.1 (5.3–13.9) 13.5 (9.2–16.5) 0.870
RV strain parameters
RVS, % −12.3 ± 6.5 −11.5 ± 6.3 −13.6 ± 6.8 0.196
Basal strain, % −21.4 ± 9.3 −20.4 ± 10.7 − 23.0 ± 6.1 0.210
Mid strain, % −19 ± 7.3 −17.4 ± 7.8 − 21.6 ± 5.5 0.019
Apical strain, % − 9.3 (− 16.9 - -5.9) −8.8 (− 15.2 - -5.8) −11.1 (− 18.7 - -6.6) 0.350
Free Wall, % −17.2 ± 6.5 −16.15 ± 7.1 −19.0 ± 4.8 0.072
Data are expressed as mean ± SD or median with IQR. PH, pulmonary hypertension; RAS, mean right atrial reservoir strain; RVS, mean right ventricular strain; * =
atrial fibrillation, RA conduit and contraction function was only calculated for 59 patients (PH n = 30, non-PH n = 29).
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impairment of RA and RV strain mainly focused on pa-
tients with idiopathic or scleroderma-associated PH [13]
and/or chronic thromboembolic pulmonary hyperten-
sion [14, 21]. Precapillary PH may cause an earlier onset
and more severe impairment of right heart function.
This makes comparisons of these studies with our find-
ings difficult as individual entities of PH and different
comorbidities may have a specific impact on RA and RV
function.
Standard echocardiographic right heart function pa-
rameters used in clinical routine comprise TAPSE, RV-S
′, or FAC. In our study TAPSE and RV-S′ showed a sig-
nificant difference between PH and non-PH patients
with lower levels for both parameters in the presence of
PH while RA and RV strain parameters did not differ be-
tween PH and non-PH patients. Still there was a trend
towards lower RAS and RV free wall levels in PH
patients which should be validated in a larger sample
size. Concerning associations with hemodynamic param-
eters (mPAP and PCWP), RAS and RVS showed stron-
ger associations in patients with PH compared to
TAPSE and RV-S′. Other studies recently described that
2D STE of the RV free wall has been shown to be a feas-
ible and more accurate parameter for predicting out-
come and cardiovascular events in patients with
predominantly pre-capillary PH [11, 21, 22]. This super-
iority is mainly explained by the global assessment of
right heart function by 2D STE and higher sensitivity of
2D STE while e.g. TAPSE remains a localized, one-
dimensional measurement of the tricuspid annular mo-
tion [21, 22]. This suggests that right heart 2D STE may
be a more accurate method to detect functional myocar-
dial impairment compared to standard echocardio-
graphic parameters.
Table 4 Correlation analysis of mean right atrial (RA) and right ventricular (RV) strain parameters with invasively obtained
hemodynamic parameters
PH (n = 45) Non-PH (n = 33)

















RA area 0.297 0.050 0.189 0.219 0.043 0.814 0.281 0.126
RVED area 0.382 0.012 0.389 0.010 0.106 0.598 0.142 0.489
RVES area 0.271 0.078 0.338 0.027 − 0.026 0.899 0.026 0.900
FAC 0.089 0.572 0.130 0.407 0.157 0.434 0.031 0.882
RV base diameter 0.346 0.023 0.318 0.038 0.051 0.792 0.213 0.277
RV mid diameter 0.251 0.104 0.188 0.227 −0.182 0.343 0.182 0.355
RV apex-base
diameter
0.077 0.626 0.104 0.507 − 0.073 0.705 − 0.258 0.184
TAPSE 0.378 0.010 0.181 0.233 0.245 0.154 0.310 0.085
RV-S′ 0.323 0.037 0.166 0.294 0.453 0.10 −0.069 0.717
RVOT VTI −0.364 0.019 −0.222 0.16 0.377 0.044 0.059 0.77
RV-e‘ 0.200 0.20 0.132 0.40 0.455 0.009 0.269 0.14
RV-a‘ −0.455 0.009 −0,275 0.13 −0,104 0.58 −0.111 0.56
RA strain parameters
RAS −0.470 0.001 −0.296 0.048 −0.017 0.923 −0.177 0.334
Conduit function * −0.342 0.065 −0.171 0.366 0.259 0.175 −0.019 0.924
Contractile function * −0.335 0.071 −0.242 0.198 0.045 0.818 −0.018 0.927
RV strain parameters
RVS 0.490 0.001 0.365 0.015 −0.130 0.520 −0.052 0.802
Basal strain 0.395 0.009 0.131 0.404 0.062 0.763 −0.307 0.135
mid strain 0.443 0.003 0.260 0.092 −0.180 0.378 −0.024 0.910
Apical strain 0.461 0.002 0.348 0.220 −0.298 0.139 0.242 0.244
Free Wall 0.466 0.002 0.258 0.094 −0.277 0.265 −0.061 0.773
PH, pulmonary hypertension; mPAP, mean pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; RA, right atrial; RV, right ventricular; RVED and
RVES, RV end diastolic and end systolic; FAC, fractional area change; TAPSE, tricuspid annular plane systolic excursion; RV-S′, RV peak systolic velocity; RAS, mean
right atrial reservoir strain; * = atrial fibrillation, RA conduit and contraction function was only calculated for 59 patients (PH n = 30, non-PH n = 29); RVS =mean
right ventricular strain
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Long-term pressure overload and adaptation due to LV
dysfunction and PH may result in RV diastolic dysfunction
and affect the pressure gradient between RA and RV [5, 23],
which leads to RA remodeling, enlargement and dysfunction
[24]. Assessment of RA function can be implemented in
TTE by using 2D STE. In our study, RAS showed a moder-
ate inverse association with mPAP and a weak inverse correl-
ation with PCWP in patients with PH. Regarding RA
conduit and contractile function, associations with mPAP
and PCWP did not reach statistical significance, which may
be a result of the small sample size due to the exclusion of
AF patients for these two parameters. The reported moder-
ate associations of RAS and RVS with invasive pulmonary
pressures may be explainable by the fact that RAS and RVS
are, next to an increase of RV afterload, significantly associ-
ated with geometric and structural properties of the RA and
the RV (such as hypertrophy and remodeling processes) with
impact on compliance and wall tension, as well as on systolic
RV and LV performance [8, 25]. The results of our study,
however, demonstrate that RAS may be a valuable noninva-
sive parameter for monitoring right heart function of PH pa-
tients. Sato et al. [3] and Alenezi et al. [5] have shown that
RA reservoir, conduit and contractile function are independ-
ent predictors for mortality and hospitalization in patients
with PH (WHO group 1 and 4). Further studies are wanted
to validate whether the predictive value of RA function pa-
rameters is also applicable in patients with post-capillary PH.
Limitations
The present study has several limitations. First, it is a
single-center analysis with a relatively small patient co-
hort; while there were significant associations with inva-
sively and non-invasively assessed parameters, correlation
strength and significance may be underestimated.
Second, our cohort consisted of all-comers of the car-
diology department and many patients had multiple
other cardiovascular diseases besides PH, which may
have a relevant impact on the results. On the contrary,
this makes our findings more applicable and suitable for
daily clinical routine. Since the etiology of PH in our pa-
tient cohort was predominantly post-capillary, these re-
sults might not be applicable for pre-capillary PH. As
mentioned above, most of previous studies in this field
focussed on precapillary PH excluding patients with left
heart diseases. While long-term LV dysfunction may fi-
nally lead to post-capillary PH, it may take longer to
cause measurable functional impairments of the RA and
RV and some of our patients might not even have
reached that point yet [26, 27].
Third, this study did not include follow-up measure-
ments. Future studies are needed to investigate the prog-
nostic value of 2D STE derived RA and RV parameters
for mortality and long-term outcome in patients with
post-capillary PH.
Conclusion
Our study showed significant associations between inva-
sively assessed hemodynamic parameters and right heart
strain parameters, particularly RAS and RVS, in patients
with predominantly post-capillary PH. The analysis of
RA and RV strain may be useful for monitoring of right
heart function in these patients. Prospective studies
evaluating RA and RV strain alterations in patients with
different entities of PH are needed to clarify the prog-
nostic value of these parameters.
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